Cadrenal Therapeutics, Inc. (CVKD)
(Delayed Data from NSDQ)
$11.15 USD
+0.57 (5.39%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $10.93 -0.22 (-1.97%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Cadrenal Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CVKD 11.15 +0.57(5.39%)
Will CVKD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CVKD based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CVKD
Cadrenal Therapeutics (CVKD) to Launch Clinical Trials for Tecarfarin
Cadrenal Therapeutics announces trial plans for tecarfarin
Cadrenal Therapeutics Announces Clinical Trial Initiation Plans for Tecarfarin in Patients with ...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session